Despite Several Legal Cases, A New Orthopedic Head is Chosen as the Stryker Company’s New CEO

Stryker Corporation has assigned Kevin Lobo as the company’s new unit leader along with the selection of their new executive head. The newly assigned team leader has prompted the medical division of orthopedic devices regarding its current issues with the Rejuvenate and ABG II hip implant devices. However, some stryker hip replacement lawsuit lawyers are unsure as to what advantage this progress would bring to the case.

In July 2011, Stryker Corporation has officially associated Kevin Lobo as their unit leader who has a very impressive professional background from working in several prominent health care institutions. Lobo used to work in Johnson & Johnson’s as the head officer of finance for the McNeil Consumer Healthcare division in 2003. After three years, he was promoted as the president of Ethicon Endo Surgery which is also a branch of Johnson & Johnson’s.

Reuters said that investing specialists are carefully positive about the assignment of Lobo for the position. An expert of finance for Morgan Stanley has informed the public that the appointment of Lobo may show the plan of the company to focus on the global orthopedics business. For the past two years the sales on the orthopedic industry has remained low. Nonetheless, it is premature to say what effect Mr. Lobo’s appointment would bring to any existing stryker hipreplacement lawsuit.

Stryker is currently challenged with several legal complaints in the U.S. This has mounted since the company’s voluntarily product recall in July for Stryker Rejuvenate and ABG II modular- neck hip stem devices. These artificial hip devices are use for surgical hip replacement operations. Compared to the older hip replacement designs that are mechanically engineered into one artificial hip component, the Stryker Modular design for hip replacement device is made into a two part neck and stems components. These allow the surgeons to adjust the hip device according to the patient’s anatomical set up. The Rejuvenate hip device provides up to six stems and 16 neck adjustments. The ABG II on the other hand can have up to 10 necks and 16 stem parts.

The modular-neck and stem components is used in both metal and ceramic design. However, the metal-on-metal neck and stem hip device are reported to have high device failure rate causing serious side effects to implant patients. The negative feedback are similar to those received from the DePuy ASR hip replacement device. These negative feedback have prompted several disgruntled recipients to file a stryker hip replacement lawsuit.